From Bayer China to IVF Applications — A Summary of VeChain’s Medical Use Cases
Reform in the field of medicine has become a global priority following the impact of the global pandemic. Currently, we see a concerted effort by governments to accelerate innovation and increase the pace of change in healthcare systems. The field of medicine is, understandably, critical for society and so it has some of the most stringent compliance measures of any field. As such, innovative products and services able to comply with regulations have the power to drastically enhance people’s lives and unlock new capabilities for global healthcare systems, unlocking efficiency, creating oversight and reducing costs.
Undoubtedly, blockchain technology holds huge promise. From advancing key healthcare services to the production and supply of drugs to advanced AI imaging facilities. Blockchain will unleash wholescale disruption on our existing systems and raise the standards of healthcare globally.
As the world’s leading enterprise-tier public blockchain, VeChain is dedicated to seizing these opportunities and driving healthcare forward in a way that has never been achieved to-date. The chronology of events summarized below represents a journey we are very proud of — but it is just a starting point. From these achievements, we will continue to build and develop our technology, driving the mass adoption of blockchain forward.
We believe that VeChain will come to be recognised as a key technological innovator in the field of medicine and beyond.
With the ongoing pandemic putting healthcare systems under strain worldwide, VeChain collaborated with I-Dante to co-develop the E-HCert App, which provides an archival solution for COVID-19 RT-PCR (real time-polymerase chain reaction) and antibodies tests (Rapid Test) records. From June to August 2020, Larnaca International Airport in Cyprus adopted the E-HCert App as a digital tool in the passenger check-in process with more than 8,000 passengers using the app.
2020–05–28 Csecure Platform of Bayer China
VeChain’s ToolChain™ platform helped Bayer China launch Csecure, a traceability platform for clinical trial supply chains, which continuously captures and tracks clinical trial supply chain data. Csecure is designed to improve transparency and security in the Bayer clinical trial supply chain.
Built on VeChainThor, MyCare provides a comprehensive framework based on DNV’s hospital standards, imparting industry best-practices and facilitating risk management competence. MyCare helps companies build a foundation aligned with national requirements and provides a robust and agile approach to infection risk management. It helps enterprises take infection risk management one step further and demonstrate their proactivity in a transparent way.
Viking Line became the first shipping company in the world to be verified. This verification, which covers all seven Viking Line vessels and operations in six terminals, affirms the company’s capability to manage and prevent infection risks, including COVID-19.
Color Line, one of Europe’s largest ferry companies, announced that it received a declaration of conformity for infection risk management from DNV based on MyCare’s standards, demonstrating the adequacy of its outbreak prevention procedures. The declaration covers the company’s management system, including its six-gram cargo ships operating between Norway, Denmark, Germany, Sweden, and the corresponding terminals, and shows that the company is currently well managed and has processes in place to ensure the safety of its staff, ships, and terminals.
2020–08–06 De Cecco and MyCare — the world’s third-largest pasta manufacturer
DNV announced that De Cecco, the third largest pasta manufacturer in the world, had received the blockchain-powered verification based on the MyCare methodology infection prevention processes and measures. By adhering to the My Care methodology, De Cecco is able to identify strengths and opportunities for improvement related to the processes and activities for the prevention of COVID-19 risk and infection. The beneficiaries of this include the pasta factories of Fara San Martino and Ortona, the olive oil mills, and the business centre in Pescara.
China’s Renji Hospital, in partnership with VeChain and DNV, announced the launch of the world’s first blockchain-enabled Intelligent Tumor Treatment Center powered by VeChain ToolChain™. The center serves as a transparent, efficient, and traceable medical management solution. Combining the VeChain blockchain technology with DNV’s professional services, the facility plans to cover the full lifecycle management of the tumour treatment process in the hospital, thereby improving efficiency and patient outcomes.
VeChain and I-Dante joined hands to fully upgrade the “E-HCert App” and extend the service to all personal medical test reports. In addition to the Mediterranean Hospital of Cyprus, Aretaeio, another top private hospital in Cyprus, will also include all individual medical test reports through the E-HCert App. Starting in January 2021, the Mediterranean Hospital of Cyprus and Aretaeio Hospital will have full coverage of all medical tests from neo-crown nucleic acid to routine blood tests via the E-HCert application, with an expected average of over 100,000 people served annually.
The most recent announcement bolstering VeChain’s medicine related activities was the announcement of the ‘MyBaby’ application, built in cooperation with DNV and Renji hospital.
MyBaby is the first service of its kind to combine the merits of third-party assured data verification with the immutability of blockchain technology. All information, imagery and data trails, from imagery produced by medical tools to the delivery of the zygote itself will be securely uploaded on VeChainThor blockchain and only accessible to authorized users of the MyBaby Application.
MyBaby allows users to view and track the extraction, labelling and scoring of fertilized eggs as well as the cultivation and preservation of embryos. The application also solves the traditional problems associated with the privacy of sensitive medical data. The cryptographically secured properties of blockchain technology create a secure and reliable environment and enhance the user experience in a way that is unprecedented in the IVF field.